Agilent Technologies Form 4 details equity grants to VP Gonsalves

Rhea-AI Filing Summary

Agilent Technologies (ticker A) reported insider equity activity for its Vice President and Corporate Controller, Rodney Gonsalves. On November 18, 2025, he received 2,540 shares of common stock under Agilent’s Long-Term Performance Program, which are subject to a one-year holding period after vesting. On the same date, he surrendered 883 shares back to Agilent to cover tax liabilities related to vesting restricted stock units.

He also received 2,402 restricted stock units under the Agilent 2018 Stock Plan, which are scheduled to vest in four equal annual installments beginning November 18, 2026. Following these transactions, he beneficially owned 34,983.6872 shares directly, plus 40.192 shares held indirectly through the Gonsalves Trust, for which he and Rochelle Gonsalves serve as trustees.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gonsalves Rodney

(Last) (First) (Middle)

5301 STEVENS CREEK BLVD

(Street)

SANTA CLARA CA 95051

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	V.P., Corporate Controller

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/18/2025		A		2,540	A	$0(1)	33,464.6872	D
Common Stock	11/18/2025		F		883(2)	D	$143.84	32,581.6872	D
Common Stock	11/18/2025		A		2,402	A	$0(3)	34,983.6872	D
Common Stock								40.192	I	Gonsalves Trust(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On November 18, 2025, 2,540 shares of common stock of Agilent Technologies, Inc. were issued to the reporting person pursuant to the Agilent Technologies, Inc. Long-Term Performance Program. The shares are subject to a 1-year post-vest holding period.

2. The reporting person surrendered 883 shares to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units in accordance with Rule 16b-3.

3. Restricted Stock Units granted under the Agilent Technologies, Inc. 2018 Stock Plan, in compliance with Rule 16b-3. The restricted stock units vest in four equal annual installments beginning on November 18, 2026.

4. Shares held by the Gonsalves Trust for which Rodney and Rochelle Gonsalves are the trustees.

	/s/ Bret DiMarco, attorney-in-fact for Mr. Gonsalves	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did Agilent Technologies (A) report for Rodney Gonsalves?

The filing reports that on November 18, 2025, Rodney Gonsalves received 2,540 shares of common stock under Agilent’s Long-Term Performance Program and surrendered 883 shares to Agilent to cover tax liabilities associated with vesting restricted stock units.

What new equity awards did the Agilent Technologies (A) executive receive?

Rodney Gonsalves was granted 2,402 restricted stock units under the Agilent Technologies, Inc. 2018 Stock Plan. These units are scheduled to vest in four equal annual installments beginning on November 18, 2026.

How many Agilent Technologies (A) shares does Rodney Gonsalves beneficially own after the reported transactions?

After the reported transactions, Rodney Gonsalves beneficially owned 34,983.6872 shares of Agilent common stock directly and an additional 40.192 shares indirectly through the Gonsalves Trust.

What is the role of Rodney Gonsalves at Agilent Technologies (A)?

Rodney Gonsalves is reported as an officer of Agilent Technologies, serving as V.P., Corporate Controller, and the Form 4 is filed as a single reporting person.

Why were 883 Agilent Technologies (A) shares surrendered by the reporting person?

The filing explains that 883 shares were surrendered to Agilent Technologies, Inc. to satisfy the tax liability on the vesting of restricted stock units, in accordance with Rule 16b-3.

What is the Gonsalves Trust mentioned in the Agilent Technologies (A) Form 4?

The Gonsalves Trust holds 40.192 shares of Agilent common stock. Rodney and Rochelle Gonsalves are identified as the trustees, and these shares are reported as indirect beneficial ownership.